Mehrdad Pourfathi1,2, Yi Xin1,3, Stephen J Kadlecek1, Maurizio F Cereda4, Harrilla Profka1, Hooman Hamedani1,3, Sarmad M Siddiqui1,3, Kai Ruppert1, Nicholas A Drachman1, Jennia N Rajaei5, Rahim R Rizi1. 1. Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 2. Department of Electrical and Systems Engineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 3. Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 4. Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia, Pennsylvania, USA. 5. School of Medicine, Stanford University, Stanford, California, USA.
Abstract
PURPOSE: To investigate pulmonary metabolic alterations during progression of acute lung injury. METHODS: Using hyperpolarized [1-13 C] pyruvate imaging, we measured pulmonary lactate and pyruvate in 15 ventilated rats 1, 2, and 4 h after initiation of mechanical ventilation. Lung compliance was used as a marker for injury progression. 5 untreated rats were used as controls; 5 rats (injured-1) received 1 ml/kg and another 5 rats (injured-2) received 2 ml/kg hydrochloric acid (pH 1.25) in the trachea at 70 min. RESULTS: The mean lactate-to-pyruvate ratio of the injured-1 cohort was 0.15 ± 0.02 and 0.15 ± 0.03 at baseline and 1 h after the injury, and significantly increased from the baseline value 3 h after the injury to 0.23 ± 0.02 (P = 0.002). The mean lactate-to-pyruvate ratio of the injured-2 cohort decreased from 0.14 ± 0.03 at baseline to 0.08 ± 0.02 1 h after the injury and further decreased to 0.07 ± 0.02 (P = 0.08) 3 h after injury. No significant change was observed in the control group. Compliance in both injured groups decreased significantly after the injury (P < 0.01). CONCLUSIONS: Our findings suggest that in severe cases of lung injury, edema and hyperperfusion in the injured lung tissue may complicate interpretation of the pulmonary lactate-to-pyruvate ratio as a marker of inflammation. However, combining the lactate-to-pyruvate ratio with pulmonary compliance provides more insight into the progression of the injury and its severity. Magn Reson Med 78:2106-2115, 2017.
PURPOSE: To investigate pulmonary metabolic alterations during progression of acute lung injury. METHODS: Using hyperpolarized [1-13 C] pyruvate imaging, we measured pulmonary lactate and pyruvate in 15 ventilated rats 1, 2, and 4 h after initiation of mechanical ventilation. Lung compliance was used as a marker for injury progression. 5 untreated rats were used as controls; 5 rats (injured-1) received 1 ml/kg and another 5 rats (injured-2) received 2 ml/kg hydrochloric acid (pH 1.25) in the trachea at 70 min. RESULTS: The mean lactate-to-pyruvate ratio of the injured-1 cohort was 0.15 ± 0.02 and 0.15 ± 0.03 at baseline and 1 h after the injury, and significantly increased from the baseline value 3 h after the injury to 0.23 ± 0.02 (P = 0.002). The mean lactate-to-pyruvate ratio of the injured-2 cohort decreased from 0.14 ± 0.03 at baseline to 0.08 ± 0.02 1 h after the injury and further decreased to 0.07 ± 0.02 (P = 0.08) 3 h after injury. No significant change was observed in the control group. Compliance in both injured groups decreased significantly after the injury (P < 0.01). CONCLUSIONS: Our findings suggest that in severe cases of lung injury, edema and hyperperfusion in the injured lung tissue may complicate interpretation of the pulmonary lactate-to-pyruvate ratio as a marker of inflammation. However, combining the lactate-to-pyruvate ratio with pulmonary compliance provides more insight into the progression of the injury and its severity. Magn Reson Med 78:2106-2115, 2017.
Authors: James A Frank; Jorge A Gutierrez; Kirk D Jones; Lennell Allen; Leland Dobbs; Michael A Matthay Journal: Am J Respir Crit Care Med Date: 2002-01-15 Impact factor: 21.405
Authors: K Thind; A Chen; L Friesen-Waldner; A Ouriadov; T J Scholl; M Fox; E Wong; J VanDyk; A Hope; G Santyr Journal: Magn Reson Med Date: 2012-10-16 Impact factor: 4.668
Authors: Delphine L Chen; Thomas W Ferkol; Mark A Mintun; Jessica E Pittman; Daniel B Rosenbluth; Daniel P Schuster Journal: Am J Respir Crit Care Med Date: 2006-03-16 Impact factor: 21.405
Authors: Robert Matthew Kottmann; Ajit A Kulkarni; Katie A Smolnycki; Elizabeth Lyda; Thinesh Dahanayake; Rami Salibi; Sylvie Honnons; Carolyn Jones; Nancy G Isern; Jian Z Hu; Steven D Nathan; Geraldine Grant; Richard P Phipps; Patricia J Sime Journal: Am J Respir Crit Care Med Date: 2012-08-23 Impact factor: 21.405
Authors: Nicolas de Prost; Yan Feng; Tyler Wellman; Mauro R Tucci; Eduardo L Costa; Guido Musch; Tilo Winkler; R Scott Harris; Jose G Venegas; Wei Chao; Marcos F Vidal Melo Journal: J Nucl Med Date: 2014-10-06 Impact factor: 10.057
Authors: V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky Journal: JAMA Date: 2012-06-20 Impact factor: 56.272
Authors: Ben J Tickner; Richard O John; Soumya S Roy; Sam J Hart; Adrian C Whitwood; Simon B Duckett Journal: Chem Sci Date: 2019-03-19 Impact factor: 9.825
Authors: Ben J Tickner; Olga Semenova; Wissam Iali; Peter J Rayner; Adrian C Whitwood; Simon B Duckett Journal: Catal Sci Technol Date: 2020-01-28 Impact factor: 6.119